Latest Insider Transactions at 23and Me Holding Co. (ME)
This section provides a real-time view of insider transactions for 23and Me Holding Co. (ME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 23andMe Holding Co. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 23andMe Holding Co.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
5,279
-4.92%
|
$15,837
$3.15 P/Share
|
|
Aug 26
2024
|
Roelof Botha Director |
BUY
Grant, award, or other acquisition
|
Indirect |
179,586
+27.08%
|
$0
$0.33 P/Share
|
|
Aug 26
2024
|
Roelof Botha Director |
BUY
Grant, award, or other acquisition
|
Direct |
658,485
+50.0%
|
-
|
|
Aug 26
2024
|
Patrick S Chung Director |
BUY
Grant, award, or other acquisition
|
Direct |
860,520
+27.75%
|
$0
$0.17 P/Share
|
|
Aug 26
2024
|
Neal Mohan Director |
BUY
Grant, award, or other acquisition
|
Direct |
658,485
+42.14%
|
-
|
|
Aug 26
2024
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
853,037
+26.63%
|
$0
$0.17 P/Share
|
|
Aug 26
2024
|
Richard H Scheller Director |
BUY
Grant, award, or other acquisition
|
Direct |
658,485
+42.36%
|
-
|
|
Aug 26
2024
|
Sandra R Md Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
808,140
+24.76%
|
$0
$0.17 P/Share
|
|
Aug 26
2024
|
Peter J. Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
658,485
+40.16%
|
-
|
|
Aug 20
2024
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
110,388
-4.89%
|
$0
$0.36 P/Share
|
|
Aug 20
2024
|
William G Richards Head of Therapeutics Discovery |
SELL
Payment of exercise price or tax liability
|
Direct |
57,365
-9.1%
|
$0
$0.36 P/Share
|
|
Jun 30
2024
|
Sandra R Md Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
57,515
+12.71%
|
-
|
|
Jun 30
2024
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,337
+4.14%
|
-
|
|
Jun 30
2024
|
Peter J. Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
57,515
+15.13%
|
-
|
|
May 21
2024
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+30.69%
|
-
|
|
May 20
2024
|
William G Richards Head of Therapeutics Discovery |
SELL
Payment of exercise price or tax liability
|
Direct |
16,106
-2.49%
|
$0
$0.55 P/Share
|
|
May 20
2024
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
36,913
-2.85%
|
$0
$0.55 P/Share
|
|
May 20
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,282
-2.82%
|
$0
$0.55 P/Share
|
|
May 02
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,551
-2.99%
|
$0
$0.49 P/Share
|
|
May 02
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,551
+2.9%
|
$0
$0.42 P/Share
|
|
Apr 18
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.99%
|
$0
$0.47 P/Share
|
|
Apr 18
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.9%
|
$0
$0.42 P/Share
|
|
Apr 04
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.99%
|
$0
$0.5 P/Share
|
|
Apr 04
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.9%
|
$0
$0.42 P/Share
|
|
Mar 21
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.99%
|
$0
$0.46 P/Share
|
|
Mar 21
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.9%
|
$0
$0.42 P/Share
|
|
Mar 07
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.99%
|
$0
$0.53 P/Share
|
|
Mar 07
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.9%
|
$0
$0.42 P/Share
|
|
Feb 22
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-3.02%
|
$0
$0.61 P/Share
|
|
Feb 22
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.93%
|
$0
$0.42 P/Share
|
|
Feb 20
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40,522
-3.16%
|
$0
$0.72 P/Share
|
|
Feb 20
2024
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
42,395
-3.22%
|
$0
$0.72 P/Share
|
|
Feb 20
2024
|
William G Richards Head of Therapeutics Discovery |
SELL
Payment of exercise price or tax liability
|
Direct |
18,497
-2.78%
|
$0
$0.72 P/Share
|
|
Feb 15
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.92%
|
$0
$0.78 P/Share
|
|
Feb 15
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.84%
|
$0
$0.42 P/Share
|
|
Jan 25
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.92%
|
$0
$0.73 P/Share
|
|
Jan 25
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.84%
|
$0
$0.42 P/Share
|
|
Jan 11
2024
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.92%
|
$0
$0.72 P/Share
|
|
Jan 11
2024
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.84%
|
$0
$0.42 P/Share
|
|
Dec 28
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.92%
|
$0
$0.93 P/Share
|
|
Dec 28
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.84%
|
$0
$0.42 P/Share
|
|
Dec 14
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.92%
|
$0
$0.97 P/Share
|
|
Dec 14
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.84%
|
$0
$0.42 P/Share
|
|
Nov 30
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.92%
|
$0
$0.88 P/Share
|
|
Nov 30
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.84%
|
$0
$0.42 P/Share
|
|
Nov 20
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,627
-0.36%
|
$0
$0.91 P/Share
|
|
Nov 20
2023
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
6,208
-0.47%
|
$0
$0.91 P/Share
|
|
Nov 20
2023
|
William G Richards Head of Therapeutics Discovery |
SELL
Payment of exercise price or tax liability
|
Direct |
5,695
-0.85%
|
$0
$0.91 P/Share
|
|
Nov 16
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,548
-2.91%
|
$0
$0.77 P/Share
|
|
Nov 16
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,548
+2.83%
|
$0
$0.42 P/Share
|